Title of presentation: “Heat Shock Protein 25 Immunotherapy Post-Menopause is Superior to Estradiol in Targeting Atherogenesis, Plasma Cholesterol and PCSK9 Levels”, by Ed O’Brien, MD, FRCPC
Late breaking basic / translational science @ European Society of Cardiology Congress, Paris Sept. 3, 2019
